Streetbeat News

Equity Actions

RKT

Rocket Companies, Inc. (NYSE:RKT) reported Q2 earnings, beating analyst consensus estimates. The company reported losses of two cents per share, better than the estimated five cents per share, and sales of $1.24 billion, surpassing the estimated $983.18 million. Total liquidity was approximately $8.6 billion. The company also announced the appointment of Varun Krishna as the new CEO. RKT shares rose 1.88% in after-hours trading.

Portfolio Pulse from Ryan Gustafson

August 04, 2023 | 2:40 pm

JUPW

Jupiter Wellness has announced a temporary postponement of the spin-off and distribution of common stock of SRM Entertainment. The company has not provided a new timeline for the spin-off.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:40 pm

HAYW

Hayward Holdings has announced the pricing of a secondary offering of 22,259,780 shares of common stock by selling stockholders.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:39 pm

RYI

Ryerson Holding Corporation has announced a secondary offering of 4 million shares of common stock by a significant shareholder.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:39 pm

XLO

Xilio Therapeutics, Inc. (NASDAQ:XLO) has promoted Chris Frankenfield to the position of Chief Operating Officer. Frankenfield has over 15 years of experience in the biotechnology sector and has previously served as Xilio's Chief Legal and Administrative Officer and General Counsel. Prior to joining Xilio, he held positions at Blueprint Medicines and PricewaterhouseCoopers LLP.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:39 pm

TRIN

Trinity Capital has announced a $75 million offering of shares of common stock.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:37 pm

ABC

AmerisourceBergen Corporation (ABC) has announced a registered public offering of 10.5 million shares of its common stock.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:37 pm

PCB

PCB Bancorp (NASDAQ:PCB) has announced a stock repurchase program authorizing the repurchase of up to 720,000 shares of the company's outstanding common stock, approximately 5% of the outstanding shares. The program, which begins on August 8, 2023, and expires on August 2, 2024, will be conducted through various means such as open market transactions and privately negotiated transactions. The company also intends to enter into a 10b5-1 trading plan to permit common stock repurchase at times when it might otherwise be precluded due to insider trading laws or self-imposed trading restrictions.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:37 pm

OMGA

Omega Therapeutics (OMGA) is planning to offer and sell shares of its common stock worth up to $60 million from time to time through Jefferies.

Portfolio Pulse from Charles Gross

August 04, 2023 | 2:37 pm

CVCO

Cavco Industries' board has approved a new $100 million stock repurchase program.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:34 pm